Study: Infant Mortality decreases after “stopping” the DPT shot
Armed with Knowledge
51774660 – child getting vaccination in africa
It appears this early Guinea-Bissau study foreshadowed a line of documented injury and mortality caused by the DPT. A 2000 BMJ article found that a population of vaccinated infants, also from Guinea-Bissau, receiving one dose of DTP or polio vaccines had higher mortality than children who had received none of these vaccines. A 2004 observational study showed a doubling of the mortality rate of infants vaccinated with the single dose of DPT vaccine and increasing mortality rates after the second and third doses.[iii] A 2011 study of Guinea-Bissau females found DTP vaccine administered simultaneously with measles vaccine is also associated with increased morbidity and poor growth in girls.[iv].
In the United States, the DTP vaccine received major public spotlight and pushback after the 1985 book DPT: A Shot in the Dark was published tracing its development and describing its risks. Recently complied reports show settlements of injury and deaths from the TDap, DTP, and DPT vaccines within the United States Vaccine Court jumped 75% from $5.5 million in 2014 to $9.8 million in 2015. Read more…
VLA Comment: the TDaP is what is now recommended by the ACIP (CDC) to be given to pregnant women along with the flu shot.
The post STUDY: Infant Mortality decreases after “stopping” the DPT shot appeared first on Vaccine Liberation Army.
Source: http://vaccineliberationarmy.com/2017/03/18/study-infant-mortality-decrease-stopping-dpt-shot/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
